Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced MyocarditisAlexi Vasbinder, Salim S. Hayek, YeeAnn Chen et al.|JACC CardioOncology|2022Cited by 78
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19Alexi Vasbinder, Salim S. Hayek, Élizabeth Anderson et al.|Diabetes Care|2022Cited by 74
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosisGeorge Hindy, Salim S. Hayek, Daniel J. Tyrrell et al.|Journal of Clinical Investigation|2022Cited by 70
Cardiovascular Events After Hematopoietic Stem Cell TransplantAlexi Vasbinder, Salim S. Hayek, Christopher W. Hoeger et al.|JACC CardioOncology|2023Cited by 46
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19Alexi Vasbinder, Chelsea Meloche, Tariq U. Azam et al.|Circulation Cardiovascular Quality and Outcomes|2022Cited by 34